Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Free Cash Flow (2020 - 2025)

GoHealth's Free Cash Flow history spans 6 years, with the latest figure at -$26.8 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 422.62% year-over-year to -$26.8 million; the TTM value through Sep 2025 reached -$81.8 million, down 290.24%, while the annual FY2024 figure was -$35.3 million, 132.38% down from the prior year.
  • Free Cash Flow for Q3 2025 was -$26.8 million at GoHealth, up from -$40.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $96.1 million in Q3 2022 and bottomed at -$224.5 million in Q4 2021.
  • The 5-year median for Free Cash Flow is -$5.1 million (2024), against an average of -$13.0 million.
  • The largest annual shift saw Free Cash Flow skyrocketed 336.31% in 2022 before it crashed 719.73% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$224.5 million in 2021, then soared by 81.73% to -$41.0 million in 2022, then skyrocketed by 293.52% to $79.4 million in 2023, then crashed by 98.7% to $1.0 million in 2024, then crashed by 2701.94% to -$26.8 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Free Cash Flow are -$26.8 million (Q3 2025), -$40.6 million (Q2 2025), and -$15.5 million (Q1 2025).